Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Norbert Graf

Showing results (261-270 of 318) with videos related to

Pageof 32
Sort By:
Pediatric Radiology|April 12, 2024
Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel studyJustine N van der Beek, Jens-Peter Schenk, Carlo Morosi, et al.
Cancer Medicine|July 27, 2023
Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group studyPrakriti Roy, Sophie E van Peer, Rana Dandis, et al.
Genes, Chromosomes & Cancer|November 7, 2015
The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidneySaskia L Gooskens, Colin Kenny, Antonio Lazaro, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2020
Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study GroupClaudia Pasqualini, Rhoikos Furtwängler, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastomaElke Pfaff, Marc Remke, Dominik Sturm, et al.
Cancers|March 3, 2021
Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 ProtocolRaquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, et al.
Pediatric Blood & Cancer|April 20, 2026
Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT StudyArianna Tagarelli, Rana Dandis, Harm Van Tinteren, et al.
Nature Reviews. Urology|February 28, 2018
Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocolSaskia L Gooskens, Norbert Graf, Rhoikos Furtwängler, et al.
JCO Global Oncology|May 10, 2022
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and StudyJoaquim Caetano de Aguirre-Neto, Beatriz de Camargo, Harm van Tinteren, et al.
Expert Review of Anticancer Therapy|August 3, 2011
Management of adults with Wilms' tumor: recommendations based on international consensusHeidi Segers, Marry M van den Heuvel-Eibrink, Kathy Pritchard-Jones, et al.
Pageof 32

Showing results (261-270 of 318) with videos related to

Sort By:
Pageof 32
Pediatric Radiology|April 12, 2024
Diagnostic magnetic resonance imaging characteristics of congenital mesoblastic nephroma: a retrospective multi-center International Society of Pediatric Oncology-Renal Tumor Study Group (SIOP-RTSG) radiology panel studyJustine N van der Beek, Jens-Peter Schenk, Carlo Morosi, et al.
Cancer Medicine|July 27, 2023
Impact of the COVID-19 pandemic on paediatric renal tumour presentation and management, a SIOP renal tumour study group studyPrakriti Roy, Sophie E van Peer, Rana Dandis, et al.
Genes, Chromosomes & Cancer|November 7, 2015
The clinical phenotype of YWHAE-NUTM2B/E positive pediatric clear cell sarcoma of the kidneySaskia L Gooskens, Colin Kenny, Antonio Lazaro, et al.
European Journal of Cancer (Oxford, England : 1990)|February 29, 2020
Outcome of patients with stage IV high-risk Wilms tumour treated according to the SIOP2001 protocol: A report of the SIOP Renal Tumour Study GroupClaudia Pasqualini, Rhoikos Furtwängler, Harm van Tinteren, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 10, 2010
TP53 mutation is frequently associated with CTNNB1 mutation or MYCN amplification and is compatible with long-term survival in medulloblastomaElke Pfaff, Marc Remke, Dominik Sturm, et al.
Cancers|March 3, 2021
Outcome of Stage IV Completely Necrotic Wilms Tumour and Local Stage III Treated According to the SIOP 2001 ProtocolRaquel Dávila Fajardo, Rhoikos Furtwängler, Martine van Grotel, et al.
Pediatric Blood & Cancer|April 20, 2026
Characteristics and Survival of Patients With Wilms Tumor and Bone Metastases: A SIOP-RTSG 93-01, SIOP 2001, and UK-IMPORT StudyArianna Tagarelli, Rana Dandis, Harm Van Tinteren, et al.
Nature Reviews. Urology|February 28, 2018
Position paper: Rationale for the treatment of children with CCSK in the UMBRELLA SIOP-RTSG 2016 protocolSaskia L Gooskens, Norbert Graf, Rhoikos Furtwängler, et al.
JCO Global Oncology|May 10, 2022
International Comparisons of Clinical Demographics and Outcomes in the International Society of Pediatric Oncology Wilms Tumor 2001 Trial and StudyJoaquim Caetano de Aguirre-Neto, Beatriz de Camargo, Harm van Tinteren, et al.
Expert Review of Anticancer Therapy|August 3, 2011
Management of adults with Wilms' tumor: recommendations based on international consensusHeidi Segers, Marry M van den Heuvel-Eibrink, Kathy Pritchard-Jones, et al.
Pageof 32